Trials / Completed
CompletedNCT02365363
PERFECT Project - Part 2 - Study 3
Pulse EnRiched Food and Exercise Clinical Trials (PERFECT Project): Part 2 - Acute Effects of Pulse Ingredients in Food Products on Aerobic Endurance and Substrate Oxidation During Exercise, as Well as, the Blood Glucose, Insulin, Lactate and Food Intake Response Following an Endurance Exercise Session in Adults - Study 3
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- University of Manitoba · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The objectives are to test the acute effects of different bagels containing pulse ingredients on: 1) aerobic endurance and substrate oxidation during exercise 2) response of blood glucose, insulin and appetite to an aerobic exercise session, and 3) food intake two hours following the exercise session. We hypothesize that consumption of bagels containing pulse ingredients 60 minutes before exercise will increase aerobic endurance (lower oxygen consumption), decrease carbohydrate oxidation (greater respiratory quotient), and a reduction in lactate production during compared to the same exercise session following the ingestion of a non-pulse food. We also hypothesize that consumption of bagels containing pulse ingredients will lead to lower blood glucose, insulin, appetite and food intake, suggesting lower calorie compensation, following a 60-minute aerobic exercise session compared to the same exercise session following the ingestion of a non-pulse food.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Control | Non pulse ingredient bagel |
| OTHER | Pea flour | Pulse ingredient bagel |
| OTHER | Pea fibre | Pulse ingredient bagel |
| OTHER | Pea flour and pea fibre | Pulse ingredient bagel |
| OTHER | Pea flour and pea protein | Pulse ingredient bagel |
| OTHER | Pea flour + pea fibre + pea protein | Pulse ingredient bagel |
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2017-12-19
- Completion
- 2017-12-19
- First posted
- 2015-02-18
- Last updated
- 2023-01-23
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02365363. Inclusion in this directory is not an endorsement.